Aseptic Manufacturing Process Failures and How CDMOs Prevent Them
Sustaining sterile integrity across advanced liquid filling operations requires an unyielding engineering framework. This detailed technical analysis details how leading contract facilities identify operational vulnerabilities inside the standard aseptic manufacturing process. Learn how proactive quality management teams validate machinery loops and eliminate manual errors in 2026.
Spray Drying ASD Scale-Up Challenges for Poorly Soluble Drugs
Formulating poorly soluble molecules requires a disciplined engineering baseline to prevent early phase failure patterns. This detailed technical analysis outlines the core thermodynamic and aerodynamic challenges encountered during a formal spray drying ASD scale up program. Discover how process experts manage gas flows, optimize atomization vectors, and secure solid-state stability paths in 2026.
Latest Articles
View All ArticlesInternational
Biologics
Pharmaceuticals
Logistics & Supply Chain
AI & Automation
Quality & Regulatory
News Capsules
— weekly intelligence in 60 seconds
Latest Expert Post
Direct-to-Patient Shipments: What I Said in 2021 — and What We See in 2026
Developing biosimilars involves navigating complex manufacturing and regulatory challenges that go far beyond traditional generics. This guide explores key hurdles—from analytical characterization to large-scale production—and highlights how strategic CDMO partnerships help ensure similarity, scalability, and commercial success.
Read Full Post
Cold Chain Logistics in Biologics Manufacturing: Preventing Temperature Excursions
Maintaining the integrity of temperature-sensitive therapies is the greatest challenge in modern medicine. This guide explores how cold chain logistics biologics manufacturing protocols prevent temperature excursions, utilize real-time monitoring, and ensure regulatory compliance. Learn about specialized packaging, risk mitigation strategies, and the role of CDMOs in securing the global supply chain.
Adventitious Agent Testing in Biologics: Building a CDMO Testing Strategy That Regulators Accept
Protecting biologics from viral, bacterial, and fungal contaminants is a regulatory mandate. This 2,500-word guide details Adventitious Agent Testing strategies at CDMOs. Explore in vitro and in vivo assays, Next-Generation Sequencing (NGS) trends, and how to structure your testing program to ensure safety and clinical success.
CDMO world AI Summer Series· Launches June 15
Learn how Ai is changing pharmaceutical manufacturing — features, roundtables, live videocasts.
Original Video Programming
Executive interviews, fill-finish features, and field intelligence from inside CDMO facilities.
Launching 5/12
Leadership Video Interview Series
Candid conversations with the CEOs, COOs, and CSOs redefining contract manufacturing.
Latest Report
Field Intelligence Reports
Boots-on-the-ground dispatches from inside CDMO facilities and pilot lines.
Now: Craig Mooney from CDSG.
Library
Pharma Problem Solved
Actionable solutions in small doses — short-form expert answers.
Latest: Dr. Frank Gibson on aseptic scale-up.
Inside the Facility — CDMO Walkthrough
Want your facility featured next?
Put your capabilities in front of sponsors actively shopping for a CDMO partner.
Events to Attend
View All Events
Bio International Convention
ChemOutsourcing
CDMOworld Weekly Live Broadcast
15-Minute Industry Wrap-Up
A fast, focused live video broadcast covering the most important moves across the CDMO landscape — deals, capacity, regulatory shifts, and the people behind them.